SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-15-000023
Filing Date
2015-01-08
Accepted
2015-01-08 08:08:26
Documents
5
Period of Report
2015-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8k_010615.htm 8-K 14006
2 AMENDMENT, DATED JANUARY 6, 2015, TO TARAPOREWALA EMPLOYMENT AGREEMENT ex10-50.htm EX-10.50 8009
3 AMENDMENT, DATED JANUARY 6, 2015, TO BACKENROTH EMPLOYMENT AGREEMENT ex10-51.htm EX-10.51 7996
4 PRESS RELEASE ex99-1.htm EX-99.1 10672
5 GRAPHIC ex99-1_img001.jpg GRAPHIC 4627
  Complete submission text file 0001387131-15-000023.txt   48631
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 15514884
SIC: 2834 Pharmaceutical Preparations